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Abstract: Mesenchymal stem cell (MSC) administration is a promising adjuvant therapy 
to treat tissue injury. However, MSC survival after administration is often hampered by 
oxidative stress at the site of injury. Heme oxygenase (HO) generates the cytoprotective 
effector molecules biliverdin/bilirubin, carbon monoxide (CO) and iron/ferritin by breaking 
down heme. Since HO-activity mediates anti-apoptotic, anti-inflammatory, and anti-oxidative 
effects, we hypothesized that modulation of the HO-system affects MSC survival.  
Adipose-derived MSCs (ASCs) from wild type (WT) and HO-2 knockout (KO) mice were 
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isolated and characterized with respect to ASC marker expression. In order to analyze 
potential modulatory effects of the HO-system on ASC survival, WT and HO-2 KO  
ASCs were pre-treated with HO-activity modulators, or downstream effector molecules 
biliverdin, bilirubin, and CO before co-exposure of ASCs to a toxic dose of H2O2. 
Surprisingly, sensitivity to H2O2-mediated cell death was similar in WT and HO-2 KO 
ASCs. However, pre-induction of HO-1 expression using curcumin increased ASC survival 
after H2O2 exposure in both WT and HO-2 KO ASCs. Simultaneous inhibition of HO-activity 
resulted in loss of curcumin-mediated protection. Co-treatment with glutathione precursor 
N-Acetylcysteine promoted ASC survival. However, co-incubation with HO-effector 
molecules bilirubin and biliverdin did not rescue from H2O2-mediated cell death, whereas 
co-exposure to CO-releasing molecules-2 (CORM-2) significantly increased cell survival, 
independently from HO-2 expression. Summarizing, our results show that curcumin 
protects via an HO-1 dependent mechanism against H2O2-mediated apoptosis, and likely 
through the generation of CO. HO-1 pre-induction or administration of CORMs may thus 
form an attractive strategy to improve MSC therapy. 
Keywords: adipose-derived mesenchymal stem cells; oxidative stress; apoptosis; heme 
oxygenase; carbon monoxide 
 
1. Introduction 
Administration of mesenchymal stem cells (MSCs) forms a promising novel adjuvant treatment to 
improve tissue repair [1–4]. MSCs have been shown to accelerate dermal wound healing and can 
regenerate diverse injured organs, such as kidney, lung and heart [5–9]. MSCs are a heterogeneous 
population of fibroblast-like, multipotent stem cells characterized by their ability to differentiate into 
mature cells of the mesodermal lineage, like osteoblasts, chondrocytes, adipocytes, endothelial cells, and 
myocytes, and into cells outside the mesodermal lineage, such as keratinocytes, and fibroblasts [3,10–12]. 
Adipose tissue forms an easy accessible source for isolating MSCs for the use in (autologous) 
regenerative medicine and may therefore be a better alternative than MSCs isolated from other sources, 
such as bone marrow (BM) [13–16]. These adipose-derived MSCs (ASCs) are abundantly present in 
adipose tissue, easy to isolate, and highly proliferative. In addition, they secrete extensively regenerative 
factors, such as hepatocyte growth factor, vascular endothelial growth factor, basic fibroblast growth 
factor, interleukin (IL)-6, -7, -8, and -11, and stromal cell-derived factor-1 (SDF-1) [14–16]. 
Despite the promising utilization of MSCs in regenerative medicine, the low survival after 
administration and the limited migration of MSCs to the site of injury limits their therapeutic  
efficacy [17,18]. Local administration to the site of injury may attenuate the problems with MSC 
migration. However, MSC administration in the vicinity of the injured tissue may also affect MSC 
survival, as the wound microenvironment harbors excessive levels of inflammatory and oxidative 
mediators, hypoxia, and limited blood flow [19]. Oxidative and inflammatory stresses are known 
causes of MSC death [17,18,20]. Cells have several mechanisms to protect themselves against 
inflammatory and oxidative insults, including cytoprotective enzyme systems (e.g., glutathione  
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S-transferase, dismutases, catalases, and peroxidases) or anti-oxidants (vitamin A, C, and E, urate, 
glutathione, and bilirubin) [21]. In addition, MSCs may upregulate anti-apoptotic and anti-oxidative 
genes [16,19]. Pre-induction of cytoprotective pathways in the ASCs may improve their therapeutic 
potential by protecting them against the harsh microenvironment [22,23]. 
The cytoprotective enzyme heme oxygenase (HO) is important for (stem) cell survival and  
functioning [17,18,24,25]. HO breaks down heme into biliverdin, free iron (Fe2+) and carbon monoxide 
(CO). Biliverdin (BV) is rapidly converted into bilirubin (BR) by biliverdin reductase [26,27]. The iron 
scavenger ferritin is co-induced by HO-derived iron and is important for protection against iron-mediated 
reactive oxygen species (ROS) formation [28]. Two distinct isoforms (HO-1 and HO-2) exist. HO-2 is 
mainly constitutively expressed whereas HO-1 is highly inducible by a variety of patho-physiological 
stimuli, such as free heme, cytokines, hypoxia, and oxidative stress [29]. HO-2 is responsible for 
maintaining normal metabolic cellular functions, and regulating physiological levels of ROS [30–32]. 
Induction of HO-1 has been demonstrated to improve MSC therapy in vivo by improving tissue 
functioning of the damaged organ, whereas inhibition of HO-activity worsened MSC therapy outcome 
in diverse pathologic conditions, such as ischemia reperfusion injury of the heart, pulmonary arterial 
hypertension, diabetes, and dermal wound healing [31,33–40]. It has been shown in vitro that HO-1 
overexpression increases BM-derived MSC survival against oxidative stress, but the exact mechanism 
remains unknown [17,34]. By contrast, induced pluripotent stem cells (iPSCs) and murine embryonic 
fibroblasts (MEFs) derived from HO-1 knockout mice accumulate higher levels of intracellular ROS 
after exposure to oxidative stress [41,42]. Moreover, HO-1 KO iPSCs and MEFs are more sensitive to 
hydrogen peroxide (H2O2)-induced cell death [41,42]. Since, the effects of HO-1 are extensively 
studied in stem cells, we investigate here the role of the HO-2 isoform in protection against oxidative 
stress. HO-2 has been shown to act in a protective manner against inflammatory and oxidative injury 
and cell apoptosis in diverse cell types [43–51]. 
In the present study we postulated that HO-2 WT ASCs would be better protected against oxidative 
stress when compared to HO-2 deficient ASCs. Additionally, we aimed to investigate the role  
of HO-activity and HO-effector molecules BR/BV and CO on ASC survival after H2O2-induced  
oxidative stress. 
2. Results and Discussion 
2.1. Isolation and Characterization of Adipose-Derived MSCs (Mesenchymal Stem Cells) (ASCs) 
ASCs were isolated from mouse (WT and HO-2 KO) adipose tissue around the inguinal lymph 
nodes and cultured in defined media as described here in Experimental Section 3. The cells adhered to 
plastic and had, as expected for ASCs, a fibroblast-like morphology. Passage three of the isolated cell 
populations were characterized for the expression of mesenchymal, endothelial, and hematopoietic 
markers by immunophenotyping (Figure 1a) and qPCR (Figure 1b). Surface antigen expression of the 
isolated cells, using flow cytometry, was consistent with literature data and our previous results [52]. 
The cells expressed ASC surface markers Sca-1, CD44, and CD105 and were negative for the exclusion 
markers CD117 (hematopoietic stem cells), CD11b (macrophages) (Figure 1a), and showed low 
expression of CD34 (endothelial/hematopoietic progenitor cells) [16,53–58]. No significant differences 
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in ASC marker expression was detected between WT and HO-2 KO ASCs. These phenotypic 
observations at the protein level were further corroborated at the mRNA level using common  
MSC markers (Figure 1b). The isolated cells expressed high mRNA levels of ASC markers Sca-1, 
CD29 [16,54–56,58], CD105, and CD106 [16,54], whereas cells were negative for exclusion markers 
CD11b, CD31 [16,53–57], CD34, hematopoietic marker CD45 [16,53–58], antigen-presenting cell 
marker CD86 [58], and CD117 showing low levels of mRNA expression, compared to housekeeping 
gene GAPDH. No significant difference in marker expression was found between WT and HO-2 KO 
ASCs. We conclude that the isolated cells are ASCs, since the marker expression profile corresponded 
well with literature data of earlier reported isolated murine ASCs. 
Figure 1. Phenotypic analysis of isolated WT (wild type) and HO-2 KO ASCs.  
(a) Percentage of positive cells for ASC exclusion markers (negative) and ASC cell surface 
markers (positive) of isolated WT and HO-2 KO ASCs, measured using flow cytometry;  
(b) mRNA levels of negative and positive ASC markers of isolated WT and HO-2 KO ASCs, 
analyzed by qPCR and presented as 2−ΔCt. No significant differences were observed between  
in the expression of selected markers between WT and HO-2 KO ASCs using both flow 
cytometry and qPCR. Data represent mean ± SD of three independent experiments. 
(a) (b) 
2.2. H2O2 Induces Cell Death in ASCs in a Dose-Dependent Manner Independently from HO-2 Expression 
ASCs were exposed to increasing concentrations of H2O2 (0–500 µM) to investigate the effect of 
oxidative stress on ASC survival. H2O2 is a strong oxidant that can cause cell death and apoptosis. 
Compared to other ROS, H2O2 is a relatively long-lived molecule commonly used in models of 
oxidative stress [59]. Exposing cells to H2O2 results in deleterious effects of hydroxyl and peroxyl 
radicals on membrane lipids and proteins, resulting in loss of mitochondrial membrane potential, 
mitochondrial dysfunction, and eventually apoptosis [60,61]. 
ASCs were exposed for 24 h to increasing concentrations of H2O2 and cell viability was assessed 
using the Alamar blue assay. This assay is based on the ability of metabolically active cells to convert 
the Alamar blue reagent into a fluorescent signal, which is directly proportional to the cellular 
viability. Damaged and non-viable cells have lower innate metabolic activity, and generate thus a 
proportionally lower signal. 
ASC viability decreased gradually after exposure to increasing concentrations of 200–500 µM H2O2 
for 24 h (Figure 2a). Exposure to doses of 250 µM H2O2 and higher had a significant cytotoxic effect 
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for both WT and HO-2 KO ASCs compared to controls (all p < 0.001). No ASCs survived at 
concentrations of 450 µM H2O2 and higher. In parallel, the amount of cells after 24 h treatment with 
H2O2 were analyzed using the picogreen assay. This assay quantifies the amount of double stranded 
DNA and is directly proportional to the amount of cells. These results were similar and corroborated 
our findings with the Alamar blue assay. The amount of cells decreased significantly at H2O2 
concentrations of 250 µM and higher, in a dose-dependent fashion for both WT and HO-2 KO ASCs 
(Figure 2b). After treatment with 350 µM H2O2 24% ± 2.5% of WT and 19.5% ± 4.9% of HO-2 KO 
ASCs survived. At this concentration, we found increased apoptosis in WT and HO-2 KO ASCs as 
measured by the increased levels of phosphatidylserine flip-flop and nuclear staining, using Annexin 
V-FITC and propodium iodide (PI), respectively (see Figure S1). Surprisingly, no significant 
difference could be observed between WT and HO-2 KO ASCs in sensitivity towards H2O2-induced 
cell death at any measured concentration. This suggests that HO-2 does not protect against  
H2O2-induced ASC death. Probably, the HO-2-activity level in naïve ASCs is too low. Although HO-2 
has been demonstrated to protect against a wide range of oxidative insults in diverse cells, the role  
of HO-2 may be cell and stressor dependent [43,44,46,49]. HO-2 can either protect or augment 
apoptosis [45,50]. In this setting, ASCs were not dependent on HO-2 for their protection against  
H2O2-induced cell death. 
Figure 2. Survival and cell amount of isolated WT and HO-2 KO ASCs after exposure to 
increasing doses of H2O2 (0–500 µM) for 24 h. (a) WT and HO-2 KO ASC survival and 
(b) amount of ASCs after H2O2-treatment were analyzed using the Alamar blue assay and 
picogreen assay, respectively. Doses of 250 µM H2O2 and higher resulted in a significant 
decreased survival and, subsequently, lower cell amounts (all p < 0.001) compared to 
untreated control. No significant differences were observed between WT and HO-2 KO 
ASCs at any concentration. A dose of 350 µM H2O2 was chosen in further experiments to 
induce ASC death. Data represent mean ± SD of three independent experiments with four 
samples per condition. * is significant different from treated control. (*** p < 0.001).  
(a) (b) 
Based on the above data, 350 µM H2O2 was chosen as cytotoxic dose since it offers an analytical 
window to assess whether the HO-system could mediate protection against oxidative stress-induced 
cell death in ASCs. 
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2.3. Can Curcumin Induce HO-1 Expression in ASCs? 
Next, we studied if we could induce the expression of HO-1 in ASCs to provide protection against 
oxidative damage. Therefore, ASCs were treated with increasing curcumin concentrations for 24 h and 
HO-1 gene transcription was subsequently assessed by qPCR (Figure 3a). 
Figure 3. HO-1 mRNA and protein expression was induced with increasing doses  
of curcumin (0–25 µM) for 24 h in isolated WT and HO-2 KO ASCs. (a) WT and  
HO-2 KO ASCs were treated with curcumin for 24 h and HO-1 mRNA expression was 
evaluated with qPCR, corrected for the housekeeping gene GAPDH and normalized to 
untreated control. HO-1 mRNA expression was significantly (p < 0.05) induced at every 
concentration in comparison to untreated control. Data represent mean ± SD of three 
independent experiments. No significant differences between WT and HO-2 KO ASCs 
were found; (b) WT and HO-2 KO ASCs were treated with curcumin for 24 h and HO-1 
protein expression was evaluated with In-Cell Western (green: β-actin, and red: HO-1);  
(c) Quantification of the In-Cell Western signal, corrected for the amount of cells with  
β-actin and related to untreated control. HO-1 protein expression was significantly  
(p < 0.05) induced at every concentration in comparison to untreated control. Data represent 
mean ± SD of three independent experiments. Four samples were analyzed per condition. 
No significant differences between WT and HO-2 KO ASCs were found; (d) WT and  
HO-2 KO ASCs were untreated or treated with 10 µM curcumin for 24 h and HO-1 protein 
expression was evaluated using immuno-fluorescent staining of chamberslides (green is 
HO-1, blue represents nuclear staining with DAPI). Data is representative of three 
independent experiments. 
(a) 
(b) 
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Figure 3. Cont. 
(c) (d) 
Exposure to curcumin for 24 h induced HO-1 mRNA levels dose-dependently in WT and HO-2  
KO ASCs compared to untreated control. No significant differences in HO-1 induction were found 
between the two genotypes. 
Next, the HO-1 protein expression after treatment with different concentrations of curcumin was 
assessed using In-Cell Western (Figure 3b). HO-1 protein expression was quantified in relation to  
β-actin protein expression (Figure 3c). We observed that HO-1 protein expression was significantly 
and dose-dependently induced after 24 h treatment with increasing doses of curcumin compared to 
untreated control in both WT and HO-2 KO ASCs. HO-1 protein expression after induction with 
curcumin was not significantly different between WT and HO-2 KO ASCs at any of the used 
concentrations. Furthermore, a plateau in expression was reached as we did not detect any difference in 
HO-1 expression levels at concentrations of 10 and 15 µM. For our next experiments we used 10 µM 
curcumin, since high concentrations of curcumin (25 µM) may cause cell death in vitro [62]. 
Treatment with 10 µM curcumin did not result in cytotoxic effects and induced HO-1 mRNA 
expression 20-fold and HO-1 protein levels roughly 7-fold compared to untreated cells. 
The HO-1 protein induction in WT and HO-2 KO ASCs was also measured using immuno-fluorescent 
staining (Figure 3d). In accordance with the mRNA and In-Cell Western expression data we 
demonstrated that HO-1 protein expression was highly up-regulated in ASCs from both genotypes 
after treatment with 10 µM curcumin in comparison with untreated control. 
There were no significant differences observed in HO-1 induction at either mRNA or protein level 
between WT and HO-2 KO ASCs after treatment with 10 µM curcumin. We demonstrated that 
curcumin acts as a potent inducer of HO-1 in both WT and HO-2 KO ASCs after treatment for 24 h. 
2.4. HO-1 Inducer Curcumin Protects against H2O2-Mediated ASC Death in a HO-2 Independent Manner 
Pre-conditioning of MSCs with cytoprotective factors can improve MSC survival against several 
injurious stressors in vitro, such as serum-free conditions, hypoxia and oxidative stress [14,63].  
It has been shown that pre-conditioning of MSCs with melatonin [61], NO-donor S-nitroso  
N-acetylpenicillamine (SNAP) [64], or overexpression of transcription factor nuclear factor-erythroid 
2-related factor 2 (nrf2) [18] can prevent MSC death caused by H2O2. Interestingly, these 
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preconditioning factors are also potent inducers of HO-1 [65–67]. Since HO-1 can protect against 
oxidative stress in diverse models [17,34], we investigated if HO-1 induction can also protect against 
oxidative stress-induced ASC death. Since HO-1 transfection is difficult to introduce safely into the 
clinic, we investigated the use of the safe pharmaceutical HO-1 inducer curcumin. Curcumin is a natural 
product that is already used in daily life as a spice in the Indian kitchen [68,69], acts as an anti-oxidant [70], 
and provides protection against a wide variety of diseases and conditions [71–73]. Moreover, a protective 
role for polyphenols, including curcumin, on BM-derived MSC survival against oxidative stress was 
recently demonstrated [21]. However, any relation to the HO-system was not investigated, and the 
survival was thought to relate to the induction of ROS-reducing enzymes glutathione peroxidase (GPX) 
and catalase [21]. 
In order to investigate the role of curcumin on H2O2-induced cell death in more detail, ASCs were 
pre-treated for 24 h with 10 µM of curcumin followed by co-treatment with 350 µM H2O2 for 24 h 
after which the cell viability was assessed using the Alamar blue assay. Pre-conditioning with 
curcumin significantly improved ASC survival during oxidative stress (Figure 4). Pre-treatment with 
10 µM curcumin increased ASC survival 2.7- and 3.6-fold in WT (Figure 4a) and HO-2 KO ASCs 
(Figure 4b), respectively, compared to cells exposed to solely 350 µM H2O2. This is further supported 
by picogreen data that showed significantly more WT and HO-2 KO ASCs when pre-treated with 
curcumin (Figure S2). Vehicle control ethanol did not increase ASC survival and cell amount 
compared to H2O2-treated control cells. Since we found that curcumin acts as a strong inducer of HO-1 
this suggests a possible role for HO-1 in ASC survival from oxidative stress. 
Figure 4. Curcumin treatment rescues WT and HO-2 KO ASCs against H2O2-induced cell 
death. (a) WT ASC and (b) HO-2 KO ASC survival after 24 h pre-treatment with curcumin, 
vehicle control, or untreated (control) and 24 h co-treatment together with 350 µM H2O2 
following an Alamar blue assay and fluorimetric quantification, related to untreated 
control. Vehicle consisted of 0.5% ethanol (curcumin solvent) in culture media. * is 
significant different from H2O2-treated control. (* p < 0.05, *** p < 0.001). Data is 
representative of three independent experiments and presents mean ± SD. For each 
condition six samples were analyzed. 
(a) (b) 
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Interestingly, transient overexpression of the human HO-1 gene in BM-derived MSCs has been 
shown to protect against oxidative stress-induced cell death [17,34]. HO-1 transfected BM-derived 
MSCs were more resistant to cell death than non-transfected MSCs after exposure to H2O2 [34]. 
Survival at 500 µM H2O2 for two hours was higher after HO-1 transfection and HO-1 induction could 
thus protect BM-MSCs to a short exposure of high concentrations H2O2. At a lower concentration of 
H2O2 but longer treatment time with H2O2 we showed also protection for ASC following curcumin 
exposure, suggesting that HO-1 induction plays a role. We further investigated the downstream 
mechanism of protection after pre-conditioning with the clinically more relevant curcumin towards an 
exposure of H2O2 for 24 h. 
In summary, curcumin provides similar protection against H2O2-induced cell death both in WT and 
HO-2 KO ASCs. A possible involvement of HO-activity will be further evaluated. 
2.5. Is Rescue from H2O2-Induced ASC Death by Curcumin Mediated by HO-Activity? 
We have shown that curcumin can protect against ASC death caused by oxidative stress. Since  
we demonstrated that curcumin induces HO-1 expression in ASCs, we next examined whether  
the protective mechanism of curcumin is HO-dependent using a specific HO-activity inhibitor.  
We used the synthetic isozyme-selective non-porphyrin HO-activity inhibitor QC-15 to test its effect 
on ASC survival. QC-15 is an imidazole-dioxolane compound that binds to the distal side of the  
heme-binding place in the HO protein and is a highly selective HO-1 activity inhibitor and has less 
potency to inhibit HO-2 activity [74–77]. 
Specifically, we investigated whether HO-1 activity inhibition would reduce ASC survival, and in 
addition, if the protecting effect of curcumin could be attenuated by co-treatment with QC-15. ASCs 
were therefore pre-incubated for 24 h with HO-activity modulators followed by a co-treatment with 
350 µM H2O2 for 24 h, after which the ASC-survival was assessed using the Alamar blue assay. 
Surprisingly, we found that co-exposure of 50 µM QC15 together with H2O2 did not influence cell 
survival when compared to cells treated with only H2O2 in both WT and HO-2 KO ASCs (Figure 5). 
This suggests that the basal levels of both HO-1 and HO-2 are not sufficient for protection. However, 
the increased survival of ASCs after 10 µM curcumin treatment, and subsequent induced HO-1 
expression, against H2O2 was completely abrogated (p < 0.001) following co-treatment with 50 µM 
QC15 in both WT as HO-2 KO ASCs. These results clearly demonstrate the protective potential  
of pre-induction of HO-1-activity in preventing oxidative stress-induced ASC death. Surprisingly, this 
is likely independent from HO-2, since no differences in survival were found between WT and HO-2 
KO ASCs. In addition, picogreen data also showed a decline in cell amount after co-treating curcumin 
with QC15 (Figure S2). However, this decrease in cell amount was not always significant for both WT 
and HO-2 KO ASCs in replicate experiments. Similar protective effects of HO-activity from injurious 
insults have also been demonstrated in other cell lines [78,79]. Induction of HO-activity by flavonoid 
baicalcin and HO-1 transfection protected raw 264.7 macrophages and vascular smooth muscle cells 
against H2O2-induced cell death. Also here, inhibition of HO-activity attenuated this protection [78,79]. 
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Figure 5. Inhibition of HO-activity abrogated the protective effect of curcumin against 
H2O2-induced cell death in isolated WT and HO-2 KO ASCs. (a) WT ASC and (b) HO-2 
KO ASC survival after 24 h pre-treatment with HO-modulators or untreated (control) and 
24 h co-treatment together with 350 µM H2O2 as measured by Alamar blue assay and 
fluorimetric quantification, related to untreated control. Vehicle consisted of 0.5% ethanol 
(curcumin solvent) in culture media. * is significant different from treated control.  
(* p < 0.05, and *** p < 0.001). Data represent a representative of three independent 
experiments and present mean ± SD. For each condition six samples were analyzed. 
(a) (b) 
Thus, curcumin-induced protection against H2O2-induced ASC death acts via induction of HO-1, 
whereas inhibition of HO-activity abrogates this protective effect. 
2.6. Do Anti-Oxidants Bilirubin, Biliverdin, and NAC Rescue from H2O2-Induced ASC Death? 
Since HO-activity protects against H2O2-mediated cell death, we investigated whether the anti-oxidative 
properties of HO-effector molecules BR and BV, or anti-oxidant N-actylcysteine (NAC) could mediate  
a protective effect. It has previously been reported that NAC; a precursor of glutathione (GSH) synthesis, 
and BR and BV can protect cells from ROS-induced cell death [62,80,81]. GSH serves as electron donor 
for glutathione peroxidase to catalyze the reduction of H2O2 into H2O, and is together with catalase  
the only defense available to metabolize H2O2 [82,83]. GSH and BR are both prominent endogenous 
anti-oxidant molecules, protecting against oxidative stress on a complementary basis and have a 
distinct antioxidant mechanism [84]. Therefore, we investigated the possible contribution of the 
different anti-oxidants NAC, BR, and BV on ASC survival. Pre-treatment for 24 h with 10 µM BR,  
10 µM BV, and 6 mM NAC and co-exposure for another 24 h with 350 µM H2O2 was performed to 
investigate the effects on ASC survival. This was assessed using the Alamar blue assay. Anti-oxidant 
NAC significantly increased cell survival compared to H2O2-treated control in WT and HO-2 KO ASCs 
6.3- and 7.1-fold, respectively (Figure 6). NAC may also influence mitochondrial biogenesis [85], and 
thus might cause bias in the Alamar blue assay, since this assay is a measure of mitochondrial activity. 
However, NAC significantly increased the cell amount compared to H2O2-treated control as confirmed 
by the picogreen assay, suggesting that NAC does not only promote mitochondrial biogenesis but also cell 
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survival (Figure S2). Since NAC can interfere with several cell viability test methods [86], we 
corroborated that cell-free NAC containing media did not influence the Alamar blue signal (data not 
shown). Increasing GSH formation results in a more reduced intracellular environment, and promotes 
cell proliferation and survival [87]. NAC has been demonstrated to promote the proliferation of 
different cell types, including adipose derived stem cells and BM stromal cells [88,89]. Surprisingly, 
the anti-oxidants BR and BV did not improve ASC survival in both WT and HO-2 KO ASCs (Figures 6 
and S2). Treatment with BR and BV in the absence of H2O2 did not result in increased cell death, as 
measured by the Alamar blue assay (data not shown). The observed differences between NAC and 
BR/BV may be related to the different targets that these anti-oxidants have [84]. GSH is hydrophilic 
and protects mainly water-soluble proteins in the cytosol, while BR and BV are more lipophilic and 
protect against lipid peroxidation of cell membranes [84]. The microenvironment largely determines 
which mechanism is needed to sustain redox homeostasis [87]. H2O2 can easily penetrate the cell 
membrane, and form hydroxyl radicals with intracellular metal ions. Treatment with H2O2 results in 
cytosolic release of cytochrome c as well as activating caspase-9 and caspase-3 and works through the 
intrinsic/mitochondrial apoptotic pathway in several cell types, including MSCs [90–95]. And hence, H2O2 
scavenging is likely more dependent on GSH, rather than BR and BV. 
Figure 6. Survival of WT and HO-2 KO ASC against H2O2-induced cell death after 
treatment with anti-oxidants. (a) WT ASC and (b) HO-2 KO ASC survival after 24 h  
pre-treatment with anti-oxidant NAC or HO-effector molecules BR and BV, and 24 h  
co-treatment together with 350 µM H2O2 following an Alamar blue assay and fluorimetric 
quantification, related to untreated control. * is significant different from treated control. 
(*** p < 0.001). Data represent a representative of three independent experiments and 
present mean ± SD. For each condition six samples were analyzed. NAC: N-acetylcysteine; 
BR: Bilirubin; BV: Biliverdin. 
(a) (b) 
Our results show that H2O2-induced cytotoxicity can be prevented by NAC, but not BR and BV.  
This suggests that HO-1-mediated ASC survival following H2O2-treatment is independent from  
HO-effector molecules BR and BV and independent of intrinsic HO-2 expression. 
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2.7. Does HO-Effector Molecule Carbon Monoxide Influence H2O2-Induced ASC Death? 
Since we have shown that HO-activity is responsible for ASC survival, and is independent from the 
effector molecules BR and BV, we next investigated the effects of the HO-effector molecule CO.  
The HO-effector molecules also provide protection through different mechanisms; BR and BV are  
anti-oxidants, whereas CO is thought to work on regulating downstream signaling pathways. 
Furthermore, CO may produce mitochondrial ROS initiating intracellular protective signaling 
pathways and maintain cells in homeostasis [96–98]. 
In order to determine whether CO could mediate the HO-induced protection against H2O2-induced 
ASC death, we treated the cells with CO releasing molecules-2 (CORM-2), and found that this resulted 
in significantly higher ASC survival in WT and HO-2 KO ASCs compared to H2O2-exposed ASCs 
(Figure 7). The absence of HO-2 expression in the ASCs in our experimental setup did not have any 
significant influence on its survival against H2O2-induced cell death. In addition, CORM-2 control and 
solvent control (DMSO) treated cells showed no protection and survival were comparable to cells 
treated with H2O2. Thus, the HO-mediated protection mechanism is likely dependent on the effects  
of CO-release. This was partly confirmed by our picogreen data (Figure S2). Here, we found that more 
cells were present after CORM-2 treatment in WT ASCs (p < 0.001) exposed to H2O2. However,  
in HO-2 KO ASCs this protective effect of CORM-2 on cell amount was not always significant in 
replicate experiments. A decrease in viability may therefore not always mean a decrease in cell 
amount. In line with our results, Lin et al. [78] also demonstrated that CO, but not BR and BV 
administration inhibited H2O2-induced cytotoxicity in macrophages, suggesting that CO is responsible 
for the protective effect caused by HO-1 overexpression in both macrophages and ASCs. Furthermore, the 
ruthenium-based CORM-2 and CORM-2 control have been demonstrated to be potent inducers of HO-1, 
which could have further boosted the protective effects of CORM-2 via a positive feedback loop [99,100]. 
Preliminary experiments show indeed induction of HO-1 following exposure to CORM-2 and to a lower 
extent for CORM-2 control. This positive feedback between HO-1 and CO (and nrf-2) has previously 
been demonstrated in hepatocytes [101] and vascular endothelium cells [102]. 
The down-stream protective effects of CO can be mediated by several protective signaling 
pathways. Pre-treatment with CORM-2 increases mitochondrial ROS signaling, which leads to  
pre-conditioning of the cells, making them more resistant to secondary stresses with H2O2 [103,104]. 
In addition, CO may activate diverse other downstream signaling pathways, including nrf-2, guanylate 
cyclase, p38 mitogen-activated protein kinase (MAPK), PI3K-Akt, and iNOS [98,102,104]. Finally, 
CO can reduce the production of ROS in cells treated with H2O2, probably by preventing the formation  
of hydroxyl radicals by binding to ionized iron [105]. 
More research is warranted to unravel the exact mechanism by which CORM-2 exerts its protective 
effects. These results suggest that CO is responsible for the observed HO-mediated ASC survival from 
oxidative stress. 
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Figure 7. CORM-2 increases WT and HO-2 KO ASC survival against H2O2-induced cell 
death. (a) WT ASC and (b) HO-2 KO ASC survival after 24 h pre-treatment with CORM-2, 
or its controls, and 24 h co-treatment together with 350 µM H2O2 following an Alamar 
blue assay and fluorimetric quantification, related to untreated control. Vehicle consisted of 
0.1% DMSO (CORM-2 and CORM-2 control solvent) in culture media. * is significant 
different from treated control. (*** p < 0.001). Experiments are performed in triplicate 
with samples in sextet. Representative graph is shown. Data are presented as mean ± SD. 
CORM-2: CO-releasing molecule-2. 
(a) (b) 
2.8. In Summary 
Administrating MSCs forms a promising therapy following pathologic tissue injury. However,  
the poor survival of MSCs following administration limits their therapeutic efficacy. In this study,  
we demonstrated that exposure of adipose-derived MSCs (ASCs) to oxidative stress results in ASC 
death and that induction of the HO-system by curcumin can attenuate this. Simultaneous inhibition of  
HO-activity could abrogate the protective effects of curcumin, demonstrating an essential role for HO-1. 
We found that also NAC improved ASC survival, whereas BR or BV did not demonstrate a protective 
effect, and thus suggest differential anti-oxidative protective mechanisms. Since administration of  
the HO-effector molecule CO also attenuated H2O2-induced ASC death, it is likely that CO mediates  
in part the protective effects of HO-1 induction. All these effects were independent from HO-2 
expression, as the results for WT and HO-2 KO ASCs were similar. 
2.9. Clinical Relevance 
Increased levels of ASCs at the site of injury may ameliorate tissue repair by their differentiation 
capacity and the excretion of paracrine factors into the tissue environment further promoting wound 
repair [106–109]. The clinical relevance of HO-1 induction in MSCs is further supported using in vivo 
models of tissue injury demonstrating improved MSC survival and tissue function [33–35,109–112]. 
Our results further emphasize the important roles of HO-1 and CO as targets for improved ASC 
survival and therapy in tissue repair. We also show that HO-2 expression is less important in mediating 
protection against oxidative insults in ASCs. 
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3. Experimental Section 
3.1. Reagents 
Biliverdin and bilirubin were purchased from Frontier Scientific, Carnforth, UK. Curcumin,  
N-acetyl-L-cysteine (NAC), tricarbonyldichlororuthenium(II)dimer (CO releasing molecule: CORM-2), 
and Ruthenium(III)chloride (CORM-2 control) were purchased from Sigma-Aldrich, Zwijndrecht,  
The Netherlands. Biliverdin, and bilirubin were prepared by dissolving this together with Trizma base 
in 2 mL 0.1 M NaOH and 5 mL H2O. The pH was adjusted to pH 8 with HCl, and further diluted till  
10 mL with H2O. An end concentration of 1 µM was used in the experiments [76]. Curcumin was 
dissolved in 99.5% ethanol at a concentration of 2 mM. The stock solutions were filter-sterilized  
(0.2 μm filter), protected from light and directly used at a final concentration of 5–15 µM. NAC was 
dissolved in phosphate buffered saline (PBS) and used at a final concentration of 6 mM [76].  
CORM-2, and CORM-2 control were both dissolved in DMSO, and diluted 1000× in work solution to 
50 μM. QC15 was produced by Dr. Szarek; Department of Chemistry, Queen’s University, Kingston, 
ON, Canada [62,113], and used at an end concentration of 50 µM. Hydrogen peroxide (H2O2) (30%) 
was purchased from Merck, Hohenbrunn, Germany. 
3.2. Mice 
The Committee for Animal Experiments of the Radboud University Nijmegen approved all procedures 
involving animals. Mice (HO-2 KO and WT with a mixed C57BL/6_129/Sv background [114])  
of 6–12 weeks in age were housed under standard specific pathogen-free housing conditions. 
3.3. Isolation and Culture of ASCs 
Adipose-derived mesenchymal stem cells (ASCs) were routinely isolated from WT and HO-2 KO 
mice as described previously [52]. In brief, adipose tissue surrounding the mouse inguinal lymph 
nodes were isolated and cut up using scalpels, followed by 30 min of incubation at 37 °C with 
digestion buffer (30 wt/v %, fat/digestion buffer). Digestion buffer consisted of complete ASC culture 
media: DMEM/F12 (Gibco, New York, NY, USA) supplemented with 2% Penicillin/Streptomycin 
(Pen/Strep) (Invitrogen, Carlsbad, CA, USA), 0.5% Amphotericin B (Invitrogen), 16 μM Biotin (Sigma 
Aldrich, St. Louis, MO, USA), 18 μM Panthotenic Acid (Sigma Aldrich), 100 μM Ascorbic Acid (Sigma 
Aldrich), and 10% Newborn Calf Serum (Sigma Aldrich), with additionally 2 mg/mL collagenase A 
(Roche, Woerden, The Netherlands) and 2 wt/v % Bovine Serum Albumin (Sigma Aldrich). Digested 
adipose tissue was filtered over a 25 μm filter and the filtrate was centrifuged 10 min at 500× g. Pellet was 
resuspended in 1 mL culture media and red blood cells were lysed with 7 mL ammonium chloride 
solution (Stem Cell technologies, Grenoble, France). Next, the cells were counted using the Beckman 
Coulter Z2 (Beckman Coulter, Woerden, The Netherlands: >4 μm <25 μm) and seeded at a 
concentration of 8000 cells/cm2 in complete culture media. 
Genotypes were confirmed using qPCR showing that HO-2 KO ASCs were in contrast to WT ASCs, 
negative for HO-2 mRNA expression (data not shown). In order to phenotypically analyze the ASC 
population we further used a panel of specific ASC markers and exclusion markers expressed on 
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macrophages, endothelial cells, and hematopoietic cells to exclude non-ASCs. Cells (passage 3) isolated 
from WT and HO-2 KO mice were tested for six different stem cell markers using flow cytometry.  
The adipose-derived cells were stained with the MSC markers Sca-1, CD44 and CD105 (BD Bioscience, 
Breda, The Netherlands; Biolegend, San Diego, CA, USA and eBioscience, San Diego, CA, USA, 
respectively) and exclusion markers CD11b, cKit and CD34 (Biolegend; BD Bioscience and eBioscience, 
respectively). In addition, we chose a subset of cell markers for Quantitative Reverse-Transcriptase PCR 
(qPCR), analysis (Table 1). ASCs up to passage number 5 were used for the different experiments. 
Table 1. Primer sequences of mouse ASC cell surface markers and cytoprotective enzymes. 
Gene Name Sense Antisense 
Cell Surface Marker 
CD45 5'-GACAGAGTGCAAAGGAGACC-3' 5'-ATCACTGGGTGTAGGTGTTTG-3' 
Sca1 5'-AGCAGTTATTGTGGATTCTC-3' 5'-TAGTACCCAGGATCTCCATAC-3' 
CD105 5'-TTGTACCCACAACAGGTCTC-3' 5'-GGTGGTAAACGTCACCTCAC-3' 
CD29 5'-AAATTGAGATCAGGAGAACCAC-3' 5'-GGTAATCTTCAGCCCTCTTG-3' 
CD11b 5'-CTGGTCACAGCCCTAGCC-3' 5'-TTTGCATTCTCTTGGAAGGTC-3' 
CD31 5'-CTGGTGCTCTATGCAAGC-3' 5'-GCTGTTGATGGTGAAGGAG-3' 
CD34 5'-TGAGTCTGCTGCATCTAAATAAC-3' 5'-CTCATTGGTAGGAACTGATGG-3' 
CD117 5'-GCCAGACAGCCACGTCTC-3' 5'-CTGATTGTGCTGGATGGATG-3' 
CD106 5'-CGTGGACATCTACTCTTTCC-3' 5'-TGTAAACTGGGTAAATGTCTGG-3' 
CD86 5'-GTCAGTGATCGCCAACTTC-3' 5'-TCTTCTTAGGTTTCGGGTGAC-3' 
Housekeeping Gene 
GAPDH 5'-GGCAAATTCAACGGCACA-3' 5'-GTTAGTGGGGTCTCGCTCCTG-3' 
Cytoprotective Enzymes 
HO-1 5'-CAACATTGAGCTGTTTGAGG-3' 5'-TGGTCTTTGTGTTCCTCTGTC-3' 
HO-2 5'-AAGGAAGGGACCAAGGAAG-3' 5'-AGTGGTGGCCAGCTTAAATAG-3' 
3.4. Heme Oxygenase Protein Expression by in-Cell Western 
ASCs were cultured in a 96-well plate, fixated with 4% paraformaldehyde (PFA) for 15 min, and 
permeabilized with 0.1% Triton X-100 in PBS for 30 min. The cells were blocked with 5% ELK 
(Campina skimmed milk powder) in PBS for 90 min. First antibody (rabbit-anti-HO-1 polyclonal 
antibody; Stressgen Biotechnologies, Victoria, BC, Canada; cat# SPA895: 6.7 μg/mL in 2.5% ELK and 
mouse-anti-β-actin monoclonal antibody; Sigma Aldrich, St. Louis, MO, USA; cat# A5441: 5 μg/mL in 
2.5% ELK) treatment was performed overnight at 4 °C. Secondary antibody treatment (goat-anti rabbit 
Alexa fluor 680; Invitrogen: Molecular Probes, Eugene, OR, USA, 2.5 μg/mL in 2.5% ELK, and  
goat-anti-mouse InfraRedDye 800; Rockland, Gilbertsville, PA, USA, 1.25 μg/mL in 2.5% ELK) was 
performed for one hour. The plate was measured using the Odyssey Imager with detection in both  
700 and 800 nm channels at an intensity of 5 and 7.5, respectively, and was analyzed using Odyssey 
software (LI-COR Biosciences, Lincoln, NE, USA; version 2.1.12). The amount of HO-1 protein 
expression was quantified in relation to the expression of β-actin protein. Since the Western blot shows 
only one specific single band following induction with curcumin, the SPA895 antibody specifically 
recognizes HO-1 (see Figure S3). Therefore, we used this antibody for immuno-fluorescent and In-Cell 
Western techniques. 
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3.5. Heme Oxygenase Protein Expression by Immuno-Fluorescent Staining 
HO-1 protein expression was also evaluated by immuno-fluorescent staining of ASCs treated with 
curcumin on plastic chamberslides (Nunc, Lab-Tek: Permanox 8-well chamberslides: Thermo 
Scientific, Rochester, NY, USA). In the chambers, cells were fixated with 4% PFA for 15 min, 
permeabilized with 0.5% Triton X-100 in PBS for 20 min, and washed with 0.05% Tween in PBS 
(PBS-T). Next, the cells were incubated with blocking buffer consisting of 2% bovine serum albumin, 
2% normal goat serum, 0.1% Triton X-100, 0.05% Tween, and 100 mM glycin in PBS for 30 min. 
First antibody (Rb-a-HO-1; Stressgen Biotechnologies; Cat# SPA895) was diluted 1:600 in blocking 
buffer without glycine and incubated on cells for 60 min. After washing with PBS-T, cells were 
incubated with secondary antibody goat-anti-rabbit alexa 594 (Life Technologies, Bleiswijk,  
The Netherlands, cat# A-11037 diluted 1:200 in blocking buffer without glycin) for 60 min. Next,  
the cells were washed with PBS-T, followed by washing with PBS, and nuclei were stained with  
4',6-diamidino-2-phenylindole (DAPI) for 10 min. Finally, cells were washed with PBS, 1:1 PBS:MQ, 
and MQ and sealed with 1,4-diazabicyclo[2.2.2]octaan (DABCO). The Zeiss Imager Z1 microscope 
(Zeiss, Sliedrecht, The Netherlands) was used to make fluorescent pictures of the cells using 
Axiovision software version 4.8 (Zeiss). 
3.6. mRNA Isolation and Quantitative-Reverse-Transcriptase-PCR 
Cells were lysed and homogenized in TRIzol (Invitrogen) and RNA was further extracted with the 
RNeasy mini kit (Qiagen, Venlo, The Netherlands). DNase treatment (Qiagen: RNase-Free DNase Set) 
was performed between the first washing steps with RW1 buffer. RNA concentration was determined 
using the nanodrop 2000 spectrophotometer (Thermo Scientific). For the reverse transcriptase 
treatment 1 µg sample RNA together with total RT mix (iScript cDNA Synthesis kit from Bio-Rad 
Laboratories, Veenendaal, The Netherlands) in a total volume of 20 µL was incubated for 5 min at  
25 °C, 30 min at 42 °C and 5 min at 85 °C. Hereafter the cDNA was diluted 10× and used for Quantitative 
Reverse-Transcriptase PCR (qPCR), using CFX96 Real-Time System (Bio-Rad Laboratories). The 
reaction was performed in 25 μL containing 5 μL cDNA, 0.6 μM primers, 12.5 μL iQ SYBR Green 
Supermix (Bio-Rad Laboratories). After incubation of 3 min, amplification was carried out for  
40 cycles of 15 s at 95 °C and 30 s at 60 °C. The melting temperature of the products was defined to 
indicate amplification specificity. All values were normalized to the housekeeping gene GAPDH. Data 
of the ASC characterization were presented as 2−ΔCt. HO-1 mRNA expression was evaluated after 
treatment with curcumin for 24 h and related to untreated control (2−ΔΔCt). All used primers are 
summarized in Table 1. 
3.7. Determination of Cell Viability 
Cells were seeded into a 96 wells plate at 2000 cells/well and after overnight culturing of the cells 
were pre-treated with HO-activity modulators or HO-system related molecules for 24 h, followed by a 
co-treatment with 350 µM hydrogen peroxide (selected from a 100–500 µM H2O2 dose range) for 24 h 
in 100 μL media. Hereafter, media was removed and replaced by media containing 10% AlamarBlue® 
Cell Viability Reagent (Invitrogen) and further incubated at 37 °C for three hours. The oxidized form 
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of this Alamar blue (resazurin) enters the cytosol where it is converted into the reduced form 
(resorufin) by mitochondrial enzyme activity. The amount of resorufin is directly proportional to the 
amount of proliferating viable cells and was measured fluorescently at 530/590 nm using the Universal 
Microplate reader FL600 (Bio-TEK instruments Inc., Winooski, VT, USA). Viability was calculated as 
percent of the difference in reduction of Alamar blue in treated versus non-treated cells, corrected for 
background signal of Alamar blue: Viability = (Ex-Eblanc)/(Ec-Eblanc) × 100; where Ex = extinction 
treatment, Ec = Extinction untreated control, and Eblanc = extinction Alamar blue background. 
3.8. Determination of Cell Amount 
The influence of pre- and co-treatment with HO-modulators and effector molecules on cell loss 
after H2O2-treatment was determined using PicoGreen dsDNA Quantification reagent (Molecular 
Probes Inc., Eugene, OR, USA). The amount of double stranded DNA can be quantified using this 
assay and this correlates to the amount of cells. After measuring the Alamar plate, the media was 
removed and the plate was washed twice with PBS. Cells were lysated by adding 0.1% Triton X-100 and 
frozen (−80 °C) and thawed (37 °C) for three consecutive times. The assay was performed according  
to the protocol of the manufacturer. The fluorescent signal was measured in a FL600 Microplate 
Fluorescence Reader (Bio-Tek Instruments Inc., Winooski, VT, USA) at excitation 485 nm, emission 
520 nm. DNA standards ranging from 0 to 2000 ng DNA/mL were used. The total amount of DNA 
after treatment was calculated using the standard curve. 
3.9. Statistical Analysis 
Data were analyzed using GraphPad Prism 5.01 software (San Diego, CA, USA). Outliers were 
tested using the Grubbs’ test. In Alamar blue experiments, one outlier was detected in a control 
untreated group of WT ASCs in two experiments. In picogreen experiments, one outlier was found in a 
control treated group of WT ASCs and one outlier was found in NAC treated group of HO-2 KO 
ASCs, in single experiments. Data was analyzed by one- or two-way analysis of variance (ANOVA) 
with Bonferroni’s multiple comparison post test. One-way ANOVA was used in survival studies and 
picogreen studies and two-way ANOVA was used in other experiments. Results were considered 
significantly different when p < 0.05 (* p < 0.05, ** p < 0.01, and *** p < 0.001). 
4. Conclusions 
Survival from H2O2-induced apoptosis was similar for WT and HO-2 KO ASCs, suggesting that the 
HO-2 isoform is not able to provide protection in this specific setting. ASC survival was ameliorated 
following pre-induction of HO-1 using the cytoprotective flavonoid curcumin. This protection by 
curcumin was mediated by HO-1 activity since simultaneous inhibition of HO-activity abrogated  
this curcumin-mediated protection. HO-effector molecules BR/BV did not provide protection, whereas 
CO protected against H2O2-induced cell death, suggesting involvement of CO in HO-1 mediated 
protection. HO-1 pre-induction by curcumin or CO exposure could therefore form a novel promising 
adjuvant strategy to promote stem cell survival during therapy. 
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